From our results, in spite of the low number of patients, it is interesting to note that among eight cases with G1–2 bladder tumour and p53 positive in the urine, six (75.0%) have recurred and four (50.0%) have progressed within a 24-month period (Table 4). This evidence concerns the gene TP53 and urinary bladder neoplasm.